Immatics GmbH
- Biotech or pharma, therapeutic R&D
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}